Pomavia 4mg Capsule: High-Potency Pomalidomide for Advanced Oncology Care
Are you searching for a dependable Pomavia 4 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced hematological therapeutics. We provide a high-authority, regulatory-compliant supply chain serving the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that critical oncology medications are delivered with pharmaceutical-grade integrity and global logistics expertise.
Detailed Product Overview: What is Pomavia 4mg?
Pomavia 4mg is an oral targeted therapy containing the active pharmaceutical ingredient Pomalidomide. It is a third-generation Immunomodulatory Imide (IMiD), specifically engineered to deliver enhanced potency in cases where earlier treatments like Lenalidomide have become ineffective. Pomavia acts as a critical intervention for complex blood cancers, working to inhibit tumor growth while simultaneously stimulating the body's natural immune defenses.
The 4mg strength is the highest available therapeutic dose for Pomalidomide, typically prescribed for aggressive management of relapsed conditions to achieve rapid tumor reduction.
Primary Therapeutic Indications:
Pomavia 4mg is clinically indicated for the following conditions:
Relapsed and Refractory Multiple Myeloma (RRMM): For adult patients who have received at least two prior therapies (including Lenalidomide and a proteasome inhibitor) and have demonstrated disease progression.
Kaposi Sarcoma (KS): Specifically for patients with AIDS-related KS who have failed highly active antiretroviral therapy (HAART) or for patients who are HIV-negative.
Mechanism of Action: How Pomavia 4 mg Works:
Pomavia 4mg employs a sophisticated multi-pathway biological approach to combat malignant cells:
Cereblon Targeting: It binds directly to the cereblon protein, triggering the degradation of essential transcription factors (Aiolos and Ikaros) that cancer cells need to survive.
Direct Cytotoxicity: It induces cell cycle arrest and apoptosis (programmed cell death) specifically in hematopoietic tumor cells.
Anti-Angiogenesis: It blocks the formation of new blood vessels that supply tumors with oxygen and nutrients, effectively "starving" the tumor.
Immune Enhancement: It stimulates T-cells and Natural Killer (NK) cells, empowering the body’s innate immune system to identify and destroy "hidden" cancer cells.
Administration and Safety Guidelines:
Usage: Taken orally, once daily, usually in cycles (e.g., 21 days on, 7 days off in a 28-day cycle).
Instruction: Capsules must be swallowed whole at the same time each day. Do not break, chew, or open them.
Critical Safety Warning: Embryo-Fetal Toxicity. Pomavia can cause severe, life-threatening birth defects. Global distribution is strictly governed by REMS (Risk Evaluation and Mitigation Strategy) protocols.
Clinical Monitoring: Regular blood tests (CBC) are required to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets).
Why Source Pomavia 4 mg from Ernest Oncology?
Direct Exporter from India: We provide direct access to GMP-certified manufacturing, ensuring 100% product authenticity and competitive bulk pricing.
Specialized Global Logistics: Expertise in cross-border pharmaceutical trade for the USA, UK, UAE, Australia, and South Africa.
Bulk Inventory Support: Reliable availability of 1mg, 2mg, 3mg, and 4mg strengths to ensure treatment cycles remain uninterrupted.
B2B Partnership: We specialize in supplying international pharmaceutical wholesalers, oncology hospitals, and government health tenders.
📞 Contact Ernest Oncology — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
📧 Email:
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 Direct Link:
